Dmitry S. Sysoev
Research Subjects
Dmitry S. Sysoev has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Stanzhevskiy
Federal State Budgetary Institution "Russian Scientific Center of Radiology and Surgical Technologies named after Academician A.M. Granov" of the Ministry of Health of the Russian Federation, St. Petersburg, Russia
4 shared publications - Dmitrii N. Maistrenko
Federal State Budgetary Institution «Russian Scientific Center of Radiology and Surgical Technolo-gies named after Academician A. M. Granov» Ministry of Health of the Russian Federation, Sankt-Peterburg
4 shared publications N. O. Tagil’TSeva
St. Petersburg State Institute of Technology (Technical University)
3 shared publicationsT. V. Bocharova
Peter the Great St. Petersburg State Polytechnic University
3 shared publications- Alexandr Valerievich Vodovatov
Saint Petersburg Research Institute of Radiation Hygiene after Professor P.V. Ramzaev, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing; Saint Petersburg State Pediatric Medical University
2 shared publications - Anastasiya V. Petryakova
Saint-Petersburg Research Institute of Radiation Hygiene after Professor P.V. Ramzaev, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing; The City Hospital No 40 of the Kurortny District
2 shared publications
Latest Publications
- Open Access
Automation of Copper-Mediated 18F-Fluorination of Aryl Pinacol Boronates Using 4-Dimethylaminopyridinium Triflate
Currently, the copper-mediated radiofluorination of aryl pinacol boronates (arylBPin) using the commercially available, air-stable Cu(OTf)2Py4 catalyst is one of the most efficient synthesis approaches, greatly facilitating access to a range of radiotracers, including drug-like molecules with nonactivated aryl scaffolds. Further adjustment of this methodology, in particular, the [18F]fluoride recovery step for the routine preparation of radiotracers, has been the focus of recent research. In our recent study, an organic solution of 4-dimethylaminopyridinium trifluoromethanesulfonate (DMAPOTf) was found to be an efficient PTC for eluting radionuclides retained on the weak anion exchange cartridge, Oasis WAX 1cc, employing the inverse sorption–elution protocol. Notably, the following Cu-mediated radiofluorination of arylBPin precursors in the presence of the Cu(OTf)2(Py)4 catalyst can be performed with high efficiency in the same solvent, bypassing not only the conventional azeotropic drying procedure but any solvent replacement. In the current study, we aimed to translate this methodology, originally developed for remote-controlled operation with manual interventions, into the automated synthesis module on the TRACERlab automation platform. The adjustment of the reagent amounts and solvents allowed for high efficiency in the radiofluorination of a series of model arylBPin substrates on the TRACERlab FXFE Pro synthesis module, which was adapted for nucleophilic radiofluorinations. The practical applicability of the developed radiofluorination approach with DMAPOTf elution was demonstrated in the automated synthesis of 6-L-[18F]FDOPA. The radiotracer was obtained with an activity yield (AY; isolated, not decay-corrected) of 5.2 ± 0.5% (n = 3), with a synthesis time of ca. 70 min on the TRACERlab FX N Pro automation platform. The obtained AY was comparable with one reported by others (6 ± 1%) using the same boronate precursor, while a slightly higher AY of 6-L-[18F]FDOPA (14.5 ± 0.5%) was achieved in our previous work using commercially available Bu4NOTf as the PTC.
Open AccessAutomation of Copper-Mediated 18F-Fluorination of Aryl Pinacol Boronates Using 4-Dimethylaminopyridinium Triflate
Currently, the copper-mediated radiofluorination of aryl pinacol boronates (arylBPin) using the commercially available, air-stable Cu(OTf)2Py4 catalyst is one of the most efficient synthesis approaches, greatly facilitating access to a range of radiotracers, including drug-like molecules with nonactivated aryl scaffolds. Further adjustment of this methodology, in particular, the [18F]fluoride recovery step for the routine preparation of radiotracers, has been the focus of recent research. In our recent study, an organic solution of 4-dimethylaminopyridinium trifluoromethanesulfonate (DMAPOTf) was found to be an efficient PTC for eluting radionuclides retained on the weak anion exchange cartridge, Oasis WAX 1cc, employing the inverse sorption–elution protocol. Notably, the following Cu-mediated radiofluorination of arylBPin precursors in the presence of the Cu(OTf)2(Py)4 catalyst can be performed with high efficiency in the same solvent, bypassing not only the conventional azeotropic drying procedure but any solvent replacement. In the current study, we aimed to translate this methodology, originally developed for remote-controlled operation with manual interventions, into the automated synthesis module on the TRACERlab automation platform. The adjustment of the reagent amounts and solvents allowed for high efficiency in the radiofluorination of a series of model arylBPin substrates on the TRACERlab FXFE Pro synthesis module, which was adapted for nucleophilic radiofluorinations. The practical applicability of the developed radiofluorination approach with DMAPOTf elution was demonstrated in the automated synthesis of 6-L-[18F]FDOPA. The radiotracer was obtained with an activity yield (AY; isolated, not decay-corrected) of 5.2 ± 0.5% (n = 3), with a synthesis time of ca. 70 min on the TRACERlab FX N Pro automation platform. The obtained AY was comparable with one reported by others (6 ± 1%) using the same boronate precursor, while a slightly higher AY of 6-L-[18F]FDOPA (14.5 ± 0.5%) was achieved in our previous work using commercially available Bu4NOTf as the PTC.
- Open Access
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 16-26
Methods of dosimetry-based treatment planning in radiopharmaceutical therapy. Part 2: Planning levels
At the present time three most common approaches are used for the planning of the radionuclide therapy: administration of the fixed activity of radionuclide in radiopharmaceutical, or administration of activity normalized per unit of body mass or body surface. That may lead to significant deviations between the prescribed and real absorbed doses in healthy organs and tissues. These deviations are associated with differences in biodistribution and pharmacokinetics of radiopharmaceutical between models and real patients. That does not allow individual planning of the treatment course for each patient since data on the accumulated activity in source regions and organs at risk is limited and uncertainty is too high for the calculation of absorbed doses. Improvements in the reliability of the absorbed dose calculation can be achieved through the use of different imaging modalities (diagnostic nuclear medicine) for the quantitative assessment of accumulated activity of radionuclides in organs and tissues and distribution of radiopharmaceutical in healthy tissues. Planning of radionuclide therapy should be personalized. The current study was aimed at the analysis of the approaches the dosimetry-based planning of radionuclide therapy presented in the Report of International Commission on Radiation Units and Measurements 96 «Dosimetry-guided radiopharmaceutical therapy», differentiated based on the possibilities of the nuclear medicine departments, including examples of levels of planning for most common radiopharmaceuticals. The results of analysis indicated that most optimal approach for Russian clinical practice is to transit to the requirements of planning level 1: to calculate and report administered activity considering patient body mass, type and stage of disease was well as prescribed clinical task. Requirements of planning level 2 are currently impossible to implement nation-wide, except for several nuclear medicine research facilities. Additionally, it is necessary to focus on the development of the methods of estimation of absorbed doses in major delineable organs.
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 16-26
Open AccessMethods of dosimetry-based treatment planning in radiopharmaceutical therapy. Part 2: Planning levels
At the present time three most common approaches are used for the planning of the radionuclide therapy: administration of the fixed activity of radionuclide in radiopharmaceutical, or administration of activity normalized per unit of body mass or body surface. That may lead to significant deviations between the prescribed and real absorbed doses in healthy organs and tissues. These deviations are associated with differences in biodistribution and pharmacokinetics of radiopharmaceutical between models and real patients. That does not allow individual planning of the treatment course for each patient since data on the accumulated activity in source regions and organs at risk is limited and uncertainty is too high for the calculation of absorbed doses. Improvements in the reliability of the absorbed dose calculation can be achieved through the use of different imaging modalities (diagnostic nuclear medicine) for the quantitative assessment of accumulated activity of radionuclides in organs and tissues and distribution of radiopharmaceutical in healthy tissues. Planning of radionuclide therapy should be personalized. The current study was aimed at the analysis of the approaches the dosimetry-based planning of radionuclide therapy presented in the Report of International Commission on Radiation Units and Measurements 96 «Dosimetry-guided radiopharmaceutical therapy», differentiated based on the possibilities of the nuclear medicine departments, including examples of levels of planning for most common radiopharmaceuticals. The results of analysis indicated that most optimal approach for Russian clinical practice is to transit to the requirements of planning level 1: to calculate and report administered activity considering patient body mass, type and stage of disease was well as prescribed clinical task. Requirements of planning level 2 are currently impossible to implement nation-wide, except for several nuclear medicine research facilities. Additionally, it is necessary to focus on the development of the methods of estimation of absorbed doses in major delineable organs.
- Open Access
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 46-56
Optimization of staging algorithm for newly detected prostate cancer by using PET/CT with 68Ga-PSMA: a retrospective study
INTRODUCTION: Prostate cancer (PC) is the most common malignancy in men worldwide and ranks third in mortality. Improvement of the results of staging of newly detected prostate cancer is rightfully associated with the active use in clinical practice of positron emission tomography combined with computed tomography (PET/CT) with radiotracers based on prostate-specific membrane antigen (PSMA) ligands.OBJECTIVE: The aim of the study was to determine the capabilities of PET/CT with 68Ga-PSMA in evaluating the prevalence of newly diagnosed breast cancer in comparison with traditional imaging techniques (computed tomography, magnetic resonance imaging and bone scan) and to determine the role of this technology in the choice of treatment algorithm.MATERIALS AND METHODS: 120 patients aged 46 to 74 years (median age 62.5 years) with histologically verified prostate cancer underwent PET/CT with 68Ga-PSMA in our center to assess disease prevalence. The selection criteria for the study were: prostate-specific antigen (PSA) level of 5 ng/ml and above, presence of newly detected, histologically verified prostate cancer, no treatment, suspected metastatic lesion of pelvic and skeletal lymph nodes according to CT, MRI and OSG. All patients were divided into groups according to PSA level and Gleason score. Statistics: Statistical processing of the results was performed by methods of variance statistics using Statistica 10.0, GraphPad Prism 9.3.1. Wilcoxon-Mann-Whitney and Friedman tests for ANOVA were used to determine the significance of differences between comparison groups. The chi-square test with Yates correction was used to determine the reliability of intergroup differences for nominal measures (such as the presence of previous recurrences). The level of correlation was assessed using Spearman criterion.RESULTS: PET/CT imaging analysis in addition to MRI, CT, and OSG data showed TNM staging changes in 63 of 120 patients (52.3%) due to the detection of additional foci of metastatic lesions. Change of data about local spread of tumor with increasing of TNM stage due to detection of pathological RFP accumulation in seminal vesicles in 10 of 120 patients (8.3%), without structural changes using conventional imaging methods. In 20 of 64 patients (31.3%), PET/CT revealed lesions of regional lymph nodes (N) that were not visualized by conventional imaging methods due to their small size. Metastatic lesions of distant lymph nodes (M1a) and bones (M1b) undetected by CT, MRI, and OSG were found in 27 (22.5%) and 32 (26.7%) of 120 patients, respectively. At the same time, foci of pathological accumulation of 68Ga-PSMA in the bones without structural changes on CT were detected in 7 and 32 patients (21.8%).DISCUSSION: One of the objectives of this study was to compare the diagnostic capabilities of standard diagnostic imaging techniques, in particular MRI, CT and Bone scan, with the hybrid technology of PET/CT with 68Ga-PSMA to improve the accuracy of PCa staging in order to determine treatment tactics. The results demonstrate minimal superiority of PET/CT with 68Ga-PSMA over MRI in terms of sensitivity (96% and 94%, respectively) in assessing local disease prevalence. Tumor invasion of the seminal vesicles, in most cases, was detected in patients with a Gleason score greater than 8. At the same time there was a tendency for an increase in the level of radiotracer accumulation in the tumor tissue of the seminal vesicles depending on the differentiation group of PCa. Analysis of the histological material obtained after the prostatectomy demonstrated tumorous invasion of the seminal vesicles in 26 (37.1%) out of 70 operated patients. Coincidence of histological examination results with PET/CT data was found in 22 patients, with MRI data — in 20 patients. The sensitivity, specificity, positive predictive value, and negative predictive value of PET/CT were 85%, 92%, 85%, and 92%, while the corresponding values from MRI were as follows: 77%, 88%, 77%, and 88%. Analyzing the levels of 68Ga-PSMA uptake in the tumor tissue, we found that with increasing prostate differentiation group, there was a persistent increase in radiotracer accumulation in the prostate tumor tissue. We also evaluated the interrelation of RFP accumulation with PSA level. The patients with PCa with PSA level ≥10.0 ng/ml demonstrated high accumulation of radiotracer accumulation compared to those with PSA CONCLUSIONS: The use of 68Ga-PSMA PET/CT in the staging of newly diagnosed and untreated cancers provides comprehensive information on the local, regional, and distant extent of the disease, and in some cases contributes to a change in TNM stage of the disease in a single study. The use of this method before planned surgical treatment of PCa can significantly reduce the risk of early postoperative relapse, especially in patients with a Gleason score of more than 7 and a PSA level greater than 20 ng/ml.
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 46-56
Open AccessOptimization of staging algorithm for newly detected prostate cancer by using PET/CT with 68Ga-PSMA: a retrospective study
INTRODUCTION: Prostate cancer (PC) is the most common malignancy in men worldwide and ranks third in mortality. Improvement of the results of staging of newly detected prostate cancer is rightfully associated with the active use in clinical practice of positron emission tomography combined with computed tomography (PET/CT) with radiotracers based on prostate-specific membrane antigen (PSMA) ligands.OBJECTIVE: The aim of the study was to determine the capabilities of PET/CT with 68Ga-PSMA in evaluating the prevalence of newly diagnosed breast cancer in comparison with traditional imaging techniques (computed tomography, magnetic resonance imaging and bone scan) and to determine the role of this technology in the choice of treatment algorithm.MATERIALS AND METHODS: 120 patients aged 46 to 74 years (median age 62.5 years) with histologically verified prostate cancer underwent PET/CT with 68Ga-PSMA in our center to assess disease prevalence. The selection criteria for the study were: prostate-specific antigen (PSA) level of 5 ng/ml and above, presence of newly detected, histologically verified prostate cancer, no treatment, suspected metastatic lesion of pelvic and skeletal lymph nodes according to CT, MRI and OSG. All patients were divided into groups according to PSA level and Gleason score. Statistics: Statistical processing of the results was performed by methods of variance statistics using Statistica 10.0, GraphPad Prism 9.3.1. Wilcoxon-Mann-Whitney and Friedman tests for ANOVA were used to determine the significance of differences between comparison groups. The chi-square test with Yates correction was used to determine the reliability of intergroup differences for nominal measures (such as the presence of previous recurrences). The level of correlation was assessed using Spearman criterion.RESULTS: PET/CT imaging analysis in addition to MRI, CT, and OSG data showed TNM staging changes in 63 of 120 patients (52.3%) due to the detection of additional foci of metastatic lesions. Change of data about local spread of tumor with increasing of TNM stage due to detection of pathological RFP accumulation in seminal vesicles in 10 of 120 patients (8.3%), without structural changes using conventional imaging methods. In 20 of 64 patients (31.3%), PET/CT revealed lesions of regional lymph nodes (N) that were not visualized by conventional imaging methods due to their small size. Metastatic lesions of distant lymph nodes (M1a) and bones (M1b) undetected by CT, MRI, and OSG were found in 27 (22.5%) and 32 (26.7%) of 120 patients, respectively. At the same time, foci of pathological accumulation of 68Ga-PSMA in the bones without structural changes on CT were detected in 7 and 32 patients (21.8%).DISCUSSION: One of the objectives of this study was to compare the diagnostic capabilities of standard diagnostic imaging techniques, in particular MRI, CT and Bone scan, with the hybrid technology of PET/CT with 68Ga-PSMA to improve the accuracy of PCa staging in order to determine treatment tactics. The results demonstrate minimal superiority of PET/CT with 68Ga-PSMA over MRI in terms of sensitivity (96% and 94%, respectively) in assessing local disease prevalence. Tumor invasion of the seminal vesicles, in most cases, was detected in patients with a Gleason score greater than 8. At the same time there was a tendency for an increase in the level of radiotracer accumulation in the tumor tissue of the seminal vesicles depending on the differentiation group of PCa. Analysis of the histological material obtained after the prostatectomy demonstrated tumorous invasion of the seminal vesicles in 26 (37.1%) out of 70 operated patients. Coincidence of histological examination results with PET/CT data was found in 22 patients, with MRI data — in 20 patients. The sensitivity, specificity, positive predictive value, and negative predictive value of PET/CT were 85%, 92%, 85%, and 92%, while the corresponding values from MRI were as follows: 77%, 88%, 77%, and 88%. Analyzing the levels of 68Ga-PSMA uptake in the tumor tissue, we found that with increasing prostate differentiation group, there was a persistent increase in radiotracer accumulation in the prostate tumor tissue. We also evaluated the interrelation of RFP accumulation with PSA level. The patients with PCa with PSA level ≥10.0 ng/ml demonstrated high accumulation of radiotracer accumulation compared to those with PSA CONCLUSIONS: The use of 68Ga-PSMA PET/CT in the staging of newly diagnosed and untreated cancers provides comprehensive information on the local, regional, and distant extent of the disease, and in some cases contributes to a change in TNM stage of the disease in a single study. The use of this method before planned surgical treatment of PCa can significantly reduce the risk of early postoperative relapse, especially in patients with a Gleason score of more than 7 and a PSA level greater than 20 ng/ml.
- Open Access
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 27-37
68Ga-FAPI-04: the first experience of clinical application in Russia
INTRODUCTION: According to the literature, 68Ga-FAPI-04 has receptor specificity for malignant neoplasms with overexpression of the fibroblast activation protein and is used to visualize various types of neoplasms, in particular head and neck cancer, gastrointestinal tract, lung, breast cancer with a high contrast ratio of the tumor to the background, and may possibly become an alternative to 18F-FDG.OBJECTIVE: The results of the first experience of using PET/CT with 68Ga-FAPI-04 in Russia.MATERIALS AND METHODS: A comparative analysis of the results of 68Ga-FAPI-04 and 18F-FDG PET/CTs with an interval of 1–3 days was carried out in 13 patients (four women and nine men) with various oncological diseases, examined from February to December 2021 in Granov Russian Research Center of Radiology and Surgical Technologies.RESULTS: In all 13 patients, it was possible to identify both primary tumors and their metastases with different tracer uptake. 68Ga-FAPI PET/CT compared with 18F-FDG PET/CT revealed more metastatic foci (135 vs 127) predominantly in the liver, peritoneum, mesentery, omentum, and brain due to low background uptake in these organs. In our observation, foci of increased 68Ga-FAPI-04 uptake localized in non-enlarged retroperitoneal lymph nodes in two patients. Also, in two patients with bone metastases from bladder cancer and stomach cancer, one false positive and one false negative result was obtained with 68Ga-FAPI-04.DISCUSSION: The high uptake of 68Ga-FAPI-04 in the tumor makes it a promising tracer for many types of cancer, especially in cases, where conventional 18F-FDG PET/CT faces limitations due to its pharmacokinetics. At the same time, PET/CT with 68Ga-FAPI-04, aimed at visualizing the tumor microenvironment, may have a higher sensitivity in detecting small lesions due to the predominance of stroma in them. 68Ga-FAPI showed better results in detecting both lytic and osteoblastic bone metastases compared to 18F-FDG.CONCLUSION: 68Ga-FAPI is a promising tracer for molecular imaging of most malignant neoplasms and requires further study. 68Ga-FAPI-04 can become an addition or a full-fledged solution when other tracers have limitations.
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 27-37
Open Access68Ga-FAPI-04: the first experience of clinical application in Russia
INTRODUCTION: According to the literature, 68Ga-FAPI-04 has receptor specificity for malignant neoplasms with overexpression of the fibroblast activation protein and is used to visualize various types of neoplasms, in particular head and neck cancer, gastrointestinal tract, lung, breast cancer with a high contrast ratio of the tumor to the background, and may possibly become an alternative to 18F-FDG.OBJECTIVE: The results of the first experience of using PET/CT with 68Ga-FAPI-04 in Russia.MATERIALS AND METHODS: A comparative analysis of the results of 68Ga-FAPI-04 and 18F-FDG PET/CTs with an interval of 1–3 days was carried out in 13 patients (four women and nine men) with various oncological diseases, examined from February to December 2021 in Granov Russian Research Center of Radiology and Surgical Technologies.RESULTS: In all 13 patients, it was possible to identify both primary tumors and their metastases with different tracer uptake. 68Ga-FAPI PET/CT compared with 18F-FDG PET/CT revealed more metastatic foci (135 vs 127) predominantly in the liver, peritoneum, mesentery, omentum, and brain due to low background uptake in these organs. In our observation, foci of increased 68Ga-FAPI-04 uptake localized in non-enlarged retroperitoneal lymph nodes in two patients. Also, in two patients with bone metastases from bladder cancer and stomach cancer, one false positive and one false negative result was obtained with 68Ga-FAPI-04.DISCUSSION: The high uptake of 68Ga-FAPI-04 in the tumor makes it a promising tracer for many types of cancer, especially in cases, where conventional 18F-FDG PET/CT faces limitations due to its pharmacokinetics. At the same time, PET/CT with 68Ga-FAPI-04, aimed at visualizing the tumor microenvironment, may have a higher sensitivity in detecting small lesions due to the predominance of stroma in them. 68Ga-FAPI showed better results in detecting both lytic and osteoblastic bone metastases compared to 18F-FDG.CONCLUSION: 68Ga-FAPI is a promising tracer for molecular imaging of most malignant neoplasms and requires further study. 68Ga-FAPI-04 can become an addition or a full-fledged solution when other tracers have limitations.
- Open Access
- 16 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 9-15
Methods of dosimetry-based treatment planning in radiopharmaceutical therapy. Part 1: terminology and definitions
Existing drawbacks of the radionuclide therapy planning may lead to the excessive irradiation of the healthy organs and tissues that is associated with the development of deterministic and stochastic effects. In some cases absorbed dose in region of interest (lesion) can be lower than prescribed therapeutic dose. That reduces the effectiveness of radionuclide therapy and reduces survival rate of patients. These problems are associated with administration of the fixed activity of radionuclide in radiopharmaceutical, or administration of activity normalized per unit of body mass or body surface. That approach does not allow assessing absorbed doses in lesions or healthy tissues for individual patients. Report of International Commission on Radiation Units and Measurements 96 «Dosimetry-guided radiopharmaceutical therapy», published in 2021, presents modern approaches for the dosimetric planning of radionuclide therapy based on the individualized assessment of absorbed doses in organs and tissues. This study was aimed at the analysis of proposed in Report 96 methods of classification of irradiated regions, organs and tissues based on example of radionuclide therapy with 177Lu-DOTATATE. Proposed terms and definitions are harmonized with previous reports of International Commission on Radiation Units and Measurements on external radiation therapy. Terms and definitions analyzed in the current study will be used in the following studies aimed at the development of the requirements on dosimetric planning of radionuclide therapy.
- 16 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 9-15
Open AccessMethods of dosimetry-based treatment planning in radiopharmaceutical therapy. Part 1: terminology and definitions
Existing drawbacks of the radionuclide therapy planning may lead to the excessive irradiation of the healthy organs and tissues that is associated with the development of deterministic and stochastic effects. In some cases absorbed dose in region of interest (lesion) can be lower than prescribed therapeutic dose. That reduces the effectiveness of radionuclide therapy and reduces survival rate of patients. These problems are associated with administration of the fixed activity of radionuclide in radiopharmaceutical, or administration of activity normalized per unit of body mass or body surface. That approach does not allow assessing absorbed doses in lesions or healthy tissues for individual patients. Report of International Commission on Radiation Units and Measurements 96 «Dosimetry-guided radiopharmaceutical therapy», published in 2021, presents modern approaches for the dosimetric planning of radionuclide therapy based on the individualized assessment of absorbed doses in organs and tissues. This study was aimed at the analysis of proposed in Report 96 methods of classification of irradiated regions, organs and tissues based on example of radionuclide therapy with 177Lu-DOTATATE. Proposed terms and definitions are harmonized with previous reports of International Commission on Radiation Units and Measurements on external radiation therapy. Terms and definitions analyzed in the current study will be used in the following studies aimed at the development of the requirements on dosimetric planning of radionuclide therapy.
- 1 July 2015
- Published by Pleiades Publishing Ltd in Glass Physics and Chemistry
- Vol. 41 (4) , 378-384
Radiation-induced color centers in phosphogermanate glass-like materials
The effect of germanium oxide on the nomenclature and nature of color centers responsible for the induced adsorption of activated phosphate glass was investigated. The spectra of the gamma-irradiated glass based on La(PO3)3 with the GeO2 content not exceeding 40 mol % were recorded and analyzed. It was suggested that the existence of an isosbestic point indicated the interaction of two independent subsystems: phosphate and germinate ones. The model composition corresponded to 5GeO2 · 10La2O3 · 85P2O5. Partic-ipation of the Eu3+ in the suppression of the induced absorption in the region of 400 nm (25000 cm–1), which was due to the [PO3 2-] centers, was demonstrated. The spectra of the induced absorption of the glass produced under reductive conditions both the initial ones and the ones containing Tb2O3 were practically identical and demonstrated a lack of the induced absorption in the visible range of the spectrum.
- 1 July 2015
- Published by Pleiades Publishing Ltd in Glass Physics and Chemistry
- Vol. 41 (4) , 378-384
Radiation-induced color centers in phosphogermanate glass-like materials
The effect of germanium oxide on the nomenclature and nature of color centers responsible for the induced adsorption of activated phosphate glass was investigated. The spectra of the gamma-irradiated glass based on La(PO3)3 with the GeO2 content not exceeding 40 mol % were recorded and analyzed. It was suggested that the existence of an isosbestic point indicated the interaction of two independent subsystems: phosphate and germinate ones. The model composition corresponded to 5GeO2 · 10La2O3 · 85P2O5. Partic-ipation of the Eu3+ in the suppression of the induced absorption in the region of 400 nm (25000 cm–1), which was due to the [PO3 2-] centers, was demonstrated. The spectra of the induced absorption of the glass produced under reductive conditions both the initial ones and the ones containing Tb2O3 were practically identical and demonstrated a lack of the induced absorption in the visible range of the spectrum.
- 1 May 2015
- Published by Pleiades Publishing Ltd in Glass Physics and Chemistry
- Vol. 41 (3) , 265-271
Spectroscopic properties of the glass of fluoroaluminate systems with small additives of barium metaphosphate activated with the ions of rare-earth elements
Optical and EPR studies of fluoroaluminate glass based on usovite with small additives of barium metaphosphate (0.1–10 mol %) have been performed. The introduction of phosphates in the composition of the fluoride matrix of glass leads to a decrease in the crystallization ability but to the simultaneous shift of the edge of the transmission band into the high-energy spectral region. It was shown that for compositions with 1–2 mol % of barium metaphosphate this shift does not exceed 125 cm−1 at a transmission of not less than 60% to 1430 cm−1 (6.4 μm) for the samples with the thickness of 1 mm. It is supposed that glass containing 1.5–2.0 mol % Ba(PO3)2 is characterized by the mixed frame of glass different from the chain structure of fluoroaluminate and phosphate glass.
- 1 May 2015
- Published by Pleiades Publishing Ltd in Glass Physics and Chemistry
- Vol. 41 (3) , 265-271
Spectroscopic properties of the glass of fluoroaluminate systems with small additives of barium metaphosphate activated with the ions of rare-earth elements
Optical and EPR studies of fluoroaluminate glass based on usovite with small additives of barium metaphosphate (0.1–10 mol %) have been performed. The introduction of phosphates in the composition of the fluoride matrix of glass leads to a decrease in the crystallization ability but to the simultaneous shift of the edge of the transmission band into the high-energy spectral region. It was shown that for compositions with 1–2 mol % of barium metaphosphate this shift does not exceed 125 cm−1 at a transmission of not less than 60% to 1430 cm−1 (6.4 μm) for the samples with the thickness of 1 mm. It is supposed that glass containing 1.5–2.0 mol % Ba(PO3)2 is characterized by the mixed frame of glass different from the chain structure of fluoroaluminate and phosphate glass.
- 15 February 2014
- Published by Pleiades Publishing Ltd in Physics of the Solid State
- Vol. 56 (2) , 353-358
Radiation phenomena in microinhomogeneous structures of flouroaluminate glass-like materials
The simulation of the fluoroaluminate matrix with small additives of phosphates has made it possible to create low-scattering glasses with a wide transparency window in the infrared region and to study the fundamental problem on the formation of radiation defects typical for the phosphate matrix (PO 3 2− hole, PO 3 2− electron, and PO 4 2− hole defects). By comparing the spectra of induced optical absorption, electron paramagnetic resonance, and Raman scattering, it has become possible to investigate the generation of defects in the course of the successive formation of the phosphate matrix in fluoroaluminate glass. The feasibility of the formation of PO 4 2− hole centers both in single tetrahedra and upon rupture of P-O-P bridge bonds with the simultaneous formation of PO 3 2− electron centers has been shown. As a result of the revision of the nature and mechanisms of formation of radiation color centers in the studied glasses, it appears promising to introduce cerium (Ce3+) and europium (Eu3+) as protectors into these glasses.
- 15 February 2014
- Published by Pleiades Publishing Ltd in Physics of the Solid State
- Vol. 56 (2) , 353-358
Radiation phenomena in microinhomogeneous structures of flouroaluminate glass-like materials
The simulation of the fluoroaluminate matrix with small additives of phosphates has made it possible to create low-scattering glasses with a wide transparency window in the infrared region and to study the fundamental problem on the formation of radiation defects typical for the phosphate matrix (PO 3 2− hole, PO 3 2− electron, and PO 4 2− hole defects). By comparing the spectra of induced optical absorption, electron paramagnetic resonance, and Raman scattering, it has become possible to investigate the generation of defects in the course of the successive formation of the phosphate matrix in fluoroaluminate glass. The feasibility of the formation of PO 4 2− hole centers both in single tetrahedra and upon rupture of P-O-P bridge bonds with the simultaneous formation of PO 3 2− electron centers has been shown. As a result of the revision of the nature and mechanisms of formation of radiation color centers in the studied glasses, it appears promising to introduce cerium (Ce3+) and europium (Eu3+) as protectors into these glasses.